MedTrace Logo

Effect of the Erchonia® HLS™ for the Relief of Tinnitus Symptoms

NCT05091060 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2023-08-30

Study results available
· View outcomes & findings →

Summary

This study is to see if applying red low-level laser light can help to reduce tinnitus symptoms

Conditions

  • Tinnitus

Interventions

DEVICE

Erchonia HLS

56 procedure administrations with the Erchonia® HLS™ administered by the subject at home: daily procedure administrations for 8 weeks.

Sponsors & Collaborators

  • Erchonia Corporation

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-10
Primary Completion
2022-03-14
Completion
2022-03-14
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05091060 on ClinicalTrials.gov